Abacus Life Receivables

The latest receivables for ERES is $14M as of September 2026. That compares with $30M in the prior-year period — down 53.8% year over year. Investors often review this figure alongside Abacus Life's historical trend and sector peers before judging valuation or financial health.

Over the past year, ERES's receivables moved from $30M to $14M — a 53.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Abacus Life's operating scale or balance-sheet position.

A receivables figure of $14M for ERES is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ERES's receivables ($14M), review year-over-year change from $30M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.